136 related articles for article (PubMed ID: 18515523)
1. Squamous cervical lesions in women with human immunodeficiency virus: long-term follow-up.
Massad LS; Seaberg EC; Wright RL; Darragh T; Lee YC; Colie C; Burk R; Strickler HD; Watts DH
Obstet Gynecol; 2008 Jun; 111(6):1388-93. PubMed ID: 18515523
[TBL] [Abstract][Full Text] [Related]
2. Effect of HIV infection on atypical squamous cells of undetermined significance.
Duerr A; Paramsothy P; Jamieson DJ; Heilig CM; Klein RS; Cu-Uvin S; Schuman P; Anderson JR;
Clin Infect Dis; 2006 Mar; 42(6):855-61. PubMed ID: 16477565
[TBL] [Abstract][Full Text] [Related]
3. Highly active antiretroviral therapy and cervical squamous intraepithelial lesions in human immunodeficiency virus-positive women.
Ahdieh-Grant L; Li R; Levine AM; Massad LS; Strickler HD; Minkoff H; Moxley M; Palefsky J; Sacks H; Burk RD; Gange SJ
J Natl Cancer Inst; 2004 Jul; 96(14):1070-6. PubMed ID: 15265968
[TBL] [Abstract][Full Text] [Related]
4. Adjunctive high-risk human papillomavirus DNA testing is a useful option for disease risk assessment in patients with negative Papanicolaou tests without an endocervical/transformation zone sample.
Zhao C; Austin RM
Cancer; 2008 Aug; 114(4):242-8. PubMed ID: 18484643
[TBL] [Abstract][Full Text] [Related]
5. Longitudinal study of cervical squamous intraepithelial lesions in human immunodeficiency virus (HIV)-seropositive and at-risk HIV-seronegative women.
Schuman P; Ohmit SE; Klein RS; Duerr A; Cu-Uvin S; Jamieson DJ; Anderson J; Shah KV;
J Infect Dis; 2003 Jul; 188(1):128-36. PubMed ID: 12825181
[TBL] [Abstract][Full Text] [Related]
6. Screening for cervical disease in mature women: strategies for improvement.
Colgan TJ; Clarke A; Hakh N; Seidenfeld A
Cancer; 2002 Aug; 96(4):195-203. PubMed ID: 12209660
[TBL] [Abstract][Full Text] [Related]
7. Limited impact of immunosuppression and HAART on the incidence of cervical squamous intraepithelial lesions in HIV-positive women.
Heard I; Potard V; Costagliola D
Antivir Ther; 2006; 11(8):1091-6. PubMed ID: 17302379
[TBL] [Abstract][Full Text] [Related]
8. European guidelines for quality assurance in cervical cancer screening: recommendations for clinical management of abnormal cervical cytology, part 1.
Jordan J; Arbyn M; Martin-Hirsch P; Schenck U; Baldauf JJ; Da Silva D; Anttila A; Nieminen P; Prendiville W
Cytopathology; 2008 Dec; 19(6):342-54. PubMed ID: 19040546
[TBL] [Abstract][Full Text] [Related]
9. High-grade cervical abnormalities and screening intervals in New South Wales, Australia.
Schindeler S; Morrell S; Zuo Y; Baker D
J Med Screen; 2008; 15(1):36-43. PubMed ID: 18416954
[TBL] [Abstract][Full Text] [Related]
10. A Study of Pap Smears in HIV-Positive and HIV-Negative Women from a Tertiary Care Center in South India.
Gupta K; Philipose CS; Rai S; Ramapuram J; Kaur G; Kini H; Gv C; Adiga D
Acta Cytol; 2019; 63(1):50-55. PubMed ID: 30721904
[TBL] [Abstract][Full Text] [Related]
11. Human papillomavirus infection and cervical disease in human immunodeficiency virus-1-infected women.
Denny L; Boa R; Williamson AL; Allan B; Hardie D; Stan R; Myer L
Obstet Gynecol; 2008 Jun; 111(6):1380-7. PubMed ID: 18515522
[TBL] [Abstract][Full Text] [Related]
12. Cervical cancer screening in medically underserved California Latina and non-Latina women: effect of age and regularity of Pap testing.
Howell LP; Gurusinghe S; Tabnak F; Sciortino S
Cancer Detect Prev; 2009; 32(5-6):372-9. PubMed ID: 19264426
[TBL] [Abstract][Full Text] [Related]
13. Risk of invasive cervical cancer after three consecutive negative Pap smears.
Coldman A; Phillips N; Kan L; Matisic J; Benedet L; Towers L
J Med Screen; 2003; 10(4):196-200. PubMed ID: 14738657
[TBL] [Abstract][Full Text] [Related]
14. Comparative study of the ThinPrep Pap test and conventional cytology results in a Canadian cohort.
Duggan MA; Khalil M; Brasher PM; Nation JG
Cytopathology; 2006 Apr; 17(2):73-81. PubMed ID: 16548991
[TBL] [Abstract][Full Text] [Related]
15. Prevaccination distribution of human papillomavirus types in women attending at cervical cancer screening in Belgium.
Arbyn M; Benoy I; Simoens C; Bogers J; Beutels P; Depuydt C
Cancer Epidemiol Biomarkers Prev; 2009 Jan; 18(1):321-30. PubMed ID: 19124515
[TBL] [Abstract][Full Text] [Related]
16. Vulvar, vaginal, and perianal intraepithelial neoplasia in women with or at risk for human immunodeficiency virus.
Jamieson DJ; Paramsothy P; Cu-Uvin S; Duerr A;
Obstet Gynecol; 2006 May; 107(5):1023-8. PubMed ID: 16648406
[TBL] [Abstract][Full Text] [Related]
17. Cytologic-histologic correlation of screening and diagnostic Papanicolaou tests.
Chute DJ; Covell J; Pambuccian SE; Stelow EB
Diagn Cytopathol; 2006 Jul; 34(7):503-6. PubMed ID: 16783779
[TBL] [Abstract][Full Text] [Related]
18. Cytopathological pattern of cervical Pap smear according to the Bethesda system in Southwestern Saudi Arabia.
Elhakeem HA; Al-Ghamdi AS; Al-Maghrabi JA
Saudi Med J; 2005 Apr; 26(4):588-92. PubMed ID: 15900366
[TBL] [Abstract][Full Text] [Related]
19. [Detection and typing of human papilloma virus by polymerase chain reaction and hybridization assay in cervical samples with cytological abnormalities].
Ergünay K; Misirlioğlu M; Firat P; Tuncer ZS; Tuncer S; Yildiz I; Ustaçelebi S
Mikrobiyol Bul; 2008 Apr; 42(2):273-82. PubMed ID: 18697425
[TBL] [Abstract][Full Text] [Related]
20. Early detection of precursors of cervical cancer with cervical cytology and visual inspection of cervix with acetic Acid.
Dhaubhadel P; Vaidya A; Choudhary P
JNMA J Nepal Med Assoc; 2008; 47(170):71-6. PubMed ID: 18709035
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]